PL368672A1 - Nowe związki 1,2,4-triazolu - Google Patents

Nowe związki 1,2,4-triazolu

Info

Publication number
PL368672A1
PL368672A1 PL02368672A PL36867202A PL368672A1 PL 368672 A1 PL368672 A1 PL 368672A1 PL 02368672 A PL02368672 A PL 02368672A PL 36867202 A PL36867202 A PL 36867202A PL 368672 A1 PL368672 A1 PL 368672A1
Authority
PL
Poland
Prior art keywords
novel
triazole compound
triazole
compound
Prior art date
Application number
PL02368672A
Other languages
English (en)
Other versions
PL208260B1 (pl
Inventor
Hiroshi Nakamura
Soichi Kaneda
Takahiro Sato
Naoki Ashizawa
Koji Matsumoto
Takashi Iwanaga
Tsutomu Inoue
Original Assignee
Fuji Yakuhin Co, Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fuji Yakuhin Co, Ltd. filed Critical Fuji Yakuhin Co, Ltd.
Publication of PL368672A1 publication Critical patent/PL368672A1/pl
Publication of PL208260B1 publication Critical patent/PL208260B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/16—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 7
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL368672A 2002-01-28 2002-12-03 Związki 1,2,4-triazolu, lek zawierający związek oraz zastosowanie związku PL208260B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2002017825 2002-01-28

Publications (2)

Publication Number Publication Date
PL368672A1 true PL368672A1 (pl) 2005-04-04
PL208260B1 PL208260B1 (pl) 2011-04-29

Family

ID=27653386

Family Applications (1)

Application Number Title Priority Date Filing Date
PL368672A PL208260B1 (pl) 2002-01-28 2002-12-03 Związki 1,2,4-triazolu, lek zawierający związek oraz zastosowanie związku

Country Status (21)

Country Link
US (1) US7074816B2 (pl)
EP (1) EP1471065B1 (pl)
JP (1) JP3600832B2 (pl)
CN (1) CN1561340B (pl)
AR (1) AR042602A1 (pl)
AT (1) ATE387438T1 (pl)
AU (1) AU2002349754B2 (pl)
BR (1) BRPI0212775B8 (pl)
CA (1) CA2462132C (pl)
DE (1) DE60225341T2 (pl)
DK (1) DK1471065T3 (pl)
ES (1) ES2300486T3 (pl)
MX (1) MXPA04004037A (pl)
NO (1) NO326941B1 (pl)
NZ (1) NZ531673A (pl)
PL (1) PL208260B1 (pl)
PT (1) PT1471065E (pl)
RU (1) RU2293733C2 (pl)
TW (1) TWI257926B (pl)
WO (1) WO2003064410A1 (pl)
ZA (1) ZA200401777B (pl)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1826335A (zh) * 2003-07-24 2006-08-30 株式会社富士药品 1,2,4－三唑化合物的制造方法以及其中间体
US20060189811A1 (en) * 2004-07-23 2006-08-24 Fujiyakuhin Co., Ltd. Process for producing 1,2,4-triazole compound and intermediate therefor
WO2006121995A2 (en) * 2005-05-09 2006-11-16 Tap Pharmaceutical Products, Inc. Methods for treating nephrolithiasis
WO2007019153A2 (en) * 2005-08-03 2007-02-15 Tap Pharmaceutical Products, Inc. Methods for treating hypertension
US7947707B2 (en) 2005-10-07 2011-05-24 Kissei Pharmaceutical Co., Ltd. Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same
KR20090031744A (ko) * 2006-06-22 2009-03-27 닛뽕 케미파 가부시키가이샤 항암제 내성 극복제
WO2008010315A1 (en) 2006-07-19 2008-01-24 Nippon Medical School Foundation Therapeutic agent for amyotrophic lateral sclerosis
US20090124623A1 (en) * 2006-11-13 2009-05-14 Christopher Lademacher Methods for preserving and/or increasing renal function using xanthine oxidoreductase inhibitors
BRPI0718611A2 (pt) * 2006-11-13 2014-02-25 Takeda Pharmaceuticals North America Inc Métodos para preservar a função renal utilizando inibidores da xantina oxidoredutase.
EP2120956A4 (en) * 2007-01-19 2010-01-20 Takeda Pharmaceuticals North A METHODS FOR PREVENTING OR REDUCING THE NUMBER OF DROUGHT ERYTHEMES USING XANTHINE OXYDOREDUCTASE INHIBITORS AND INFLAMMATORY AGENTS
JO2784B1 (en) * 2007-10-18 2014-03-15 شركة جانسين فارماسوتيكا ان. في 5,3,1 - Triazole substitute derivative
DK2217577T3 (da) 2007-11-27 2014-10-20 Ardea Biosciences Inc Hidtil ukendte forbindelser og præparater og fremgangsmåder til anvendelse deraf
EP2165705A1 (en) 2008-09-18 2010-03-24 Centre National de la Recherche Scientifique (CNRS) Use of a compound capable of reducing the uric acid level for the prevention and/or the treatment of lung inflammation and fibrosis
US20100311756A1 (en) * 2009-01-22 2010-12-09 Takeda Pharmaceuticals North America, Inc. Methods for delaying the progression of at least one of cardiac hypertrophy, cardiac remodeling or left ventricular function or the onset of heart failure in subjects in need of treatment thereof
RU2412180C1 (ru) * 2009-07-29 2011-02-20 Государственное образовательное учреждение высшего профессионального образования "Южно-Российский государственный технический университет (Новочеркасский политехнический институт)" Способ получения 3(5)-пиридилзамещенных 5(3)-амино-1,2,4-триазолов
WO2012033941A1 (en) 2010-09-10 2012-03-15 Takeda Pharmaceuticals North America, Inc. Methods for concomitant treatment of theophylline and febuxostat
JP5862897B2 (ja) * 2010-11-01 2016-02-16 株式会社三和化学研究所 腎機能障害の予防又は治療に用いる医薬
WO2012081736A1 (en) 2010-12-17 2012-06-21 Mitsubishi Tanabe Pharma Corporation Continuous arycyclic compound
WO2012118485A1 (en) 2011-03-01 2012-09-07 Empire Technology Development Llc Temperature controlled variable reflectivity coatings
RU2476428C1 (ru) * 2011-09-01 2013-02-27 Государственное образовательное учреждение высшего профессионального образования "Южно-Российский государственный технический университет (Новочеркасский политехнический институт)" Способ получения дигидрохлорида 5-амино-3-аминометил-1,2,4-триазола
WO2013187496A1 (ja) 2012-06-15 2013-12-19 田辺三菱製薬株式会社 芳香族複素環化合物
RU2639149C2 (ru) 2012-07-25 2017-12-20 Фудзиякухин Ко., Лтд Кристаллический полиморф 4-[5-(пиридин-4-ил)-1н-1,2,4-триазол-3-ил]-пиридин-2-карбонитрила и способ его получения
CN104411686B (zh) 2012-07-25 2016-08-31 株式会社富士药品 4-[5-(吡啶-4-基)-1h-1,2,4-三唑-3-基]吡啶-2-腈的制造方法及中间体
CN103724329B (zh) * 2013-12-23 2015-02-18 济南百诺医药科技开发有限公司 4-[5-(吡啶-4-基)-1h-[1,2,4]三唑-3-基]吡啶-2-甲腈的制备方法
CN104042577B (zh) * 2014-06-13 2016-08-24 安徽省逸欣铭医药科技有限公司 一种稳定的托匹司他片及其制备方法
CN105315260A (zh) * 2014-07-29 2016-02-10 北京海步医药科技股份有限公司 一种托布司他一水合物晶型及其制备方法
CN105348264B (zh) * 2014-08-18 2018-01-16 上海医药工业研究院 一种托吡司他的合成方法
CN105367490B (zh) * 2014-08-18 2019-01-04 上海医药工业研究院 合成托吡司他的新中间体及其制备方法
CN104151297B (zh) * 2014-08-27 2016-03-16 王庆本 4-[5-(吡啶-4-基)-1h-[1，2，4]三唑-3-基]吡啶-2-甲腈的制备方法
JP6684264B2 (ja) * 2015-02-17 2020-04-22 株式会社三和化学研究所 心不全の予防又は治療のための医薬
WO2016136727A1 (ja) 2015-02-24 2016-09-01 国立大学法人鳥取大学 認知症の予防及び／又は治療のための医薬
WO2016134854A1 (en) 2015-02-25 2016-09-01 Pharmathen S.A. Methods for the preparation of topiroxostat and intermediates thereof
CN105693699B (zh) * 2015-03-30 2019-06-18 苏州晶云药物科技股份有限公司 托吡司他的晶型及其制备方法
CN104910068B (zh) * 2015-04-24 2017-07-14 南京医科大学 一种2‑氰基异烟酸酰肼1.5对甲苯磺酸盐的合成方法
CN106279111A (zh) * 2015-05-12 2017-01-04 北京济美堂医药研究有限公司 一种精制托吡司他的新方法
CN104961730B (zh) * 2015-06-18 2017-05-17 山东金城医药化工股份有限公司 托吡司他新晶型及其制备方法
CN105130958B (zh) * 2015-08-31 2017-10-31 济南康和医药科技有限公司 5‑(2‑氰基4‑吡啶基)‑3‑(4‑吡啶基)‑1,2,4‑三唑的制备工艺
CN105294656A (zh) * 2015-10-10 2016-02-03 大道隆达（北京）医药科技发展有限公司 一种托匹司他的制备工艺和方法
CN106336399A (zh) * 2015-11-03 2017-01-18 江苏悦兴药业有限公司 托匹司他工艺杂质的制备方法
CN105294584A (zh) * 2015-11-30 2016-02-03 中国医科大学 1-取代苯基-1h-1,2,3-三唑类化合物、制备方法及其用途
CN105399732A (zh) * 2015-12-07 2016-03-16 青岛正大海尔制药有限公司 一种托匹司他的制备方法
CN106008465A (zh) * 2016-03-16 2016-10-12 江苏悦兴药业有限公司 一种托匹司他杂质的合成方法
CN108250183A (zh) * 2016-12-29 2018-07-06 北京诚济制药有限公司 一种高纯度的托匹司他的制备方法
CN109721586B (zh) * 2017-10-27 2021-03-02 中国医科大学 一种5-苄基-3-吡啶基-1h-1,2,4-三唑类化合物及其制备方法和用途
CN107652271B (zh) * 2017-11-06 2020-06-16 上海中拓医药科技有限公司 一种托匹司他晶型i的制备方法
CN108017619B (zh) * 2017-12-06 2020-08-11 成都惟邦药业有限公司 一种托匹司他杂质及其制备方法
CN113354616B (zh) * 2020-03-05 2024-03-26 中国医学科学院药物研究所 二芳基-1,2,4-三唑类化合物及其制法和药物用途
CN113666909B (zh) * 2020-05-14 2024-07-02 鲁南制药集团股份有限公司 一种托匹司他的制备方法
CN114773262B (zh) * 2022-05-19 2024-05-07 兄弟科技股份有限公司 2-氰基-4-吡啶羧酸甲酯的合成方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7112373A (pl) * 1970-09-25 1972-03-28
US3947577A (en) * 1973-05-21 1976-03-30 Merck & Co., Inc. Anti-hyperuricemia composition
US3984558A (en) * 1973-05-21 1976-10-05 Merck & Co., Inc. 1,3,5-Trisubstituted-1,2,4-triazole compounds used as bronchodilators
US3928361A (en) * 1973-05-21 1975-12-23 Merck & Co Inc 1-(Sulfamoylphenylalkyl)-3,5-dipyridyl-1,2,4 triazoles
US3963731A (en) * 1973-05-21 1976-06-15 Merck & Co., Inc. Pyridyl containing 1-benzenesulfonyl triazoles
US3882134A (en) * 1973-05-21 1975-05-06 Merck & Co Inc 1-Substituted-3,5-dipyridyl-1,2,4-triazoles
US4104393A (en) * 1976-04-02 1978-08-01 Merck & Co., Inc. 1,3,5-Trisubstituted-1,2,4-triazole compounds
WO1993011433A1 (en) * 1991-12-05 1993-06-10 Wallac Oy Luminescent lanthanide chelates
JP3217846B2 (ja) * 1992-03-04 2001-10-15 クミアイ化学工業株式会社 トリアゾール誘導体及び殺虫剤
AU1130700A (en) * 1998-10-23 2000-05-15 Dow Agrosciences Llc Insecticidal 1-(substituted pyridyl)-1,2,4-triazoles
KR100838447B1 (ko) * 2001-02-21 2008-06-16 아스트라제네카 아베 헤테로폴리시클릭 화합물 및 대사향성 글루타메이트수용체 길항제로서의 그의 용도

Also Published As

Publication number Publication date
ES2300486T3 (es) 2008-06-16
JP3600832B2 (ja) 2004-12-15
RU2293733C2 (ru) 2007-02-20
ATE387438T1 (de) 2008-03-15
CN1561340B (zh) 2012-05-23
HK1067132A1 (en) 2005-04-01
NO20041075L (no) 2004-03-15
EP1471065A1 (en) 2004-10-27
CA2462132C (en) 2010-08-10
WO2003064410A1 (en) 2003-08-07
RU2004106554A (ru) 2005-07-27
BRPI0212775B1 (pt) 2017-06-06
DK1471065T3 (da) 2008-03-25
AR042602A1 (es) 2005-06-29
AU2002349754B2 (en) 2008-01-31
EP1471065B1 (en) 2008-02-27
BR0212775A (pt) 2004-10-13
TW200302222A (en) 2003-08-01
ZA200401777B (en) 2005-08-31
TWI257926B (en) 2006-07-11
NO326941B1 (no) 2009-03-16
DE60225341D1 (de) 2008-04-10
CA2462132A1 (en) 2003-08-07
EP1471065A4 (en) 2005-06-15
NZ531673A (en) 2006-06-30
PL208260B1 (pl) 2011-04-29
CN1561340A (zh) 2005-01-05
US20050004175A1 (en) 2005-01-06
MXPA04004037A (es) 2004-07-23
PT1471065E (pt) 2008-03-13
US7074816B2 (en) 2006-07-11
DE60225341T2 (de) 2009-04-09
BRPI0212775B8 (pt) 2021-05-25
JPWO2003064410A1 (ja) 2005-05-26

Similar Documents

Publication Publication Date Title
PT1471065E (pt) Novos compostos de 1,2,4-triazole
AU2002349754A1 (en) Novel 1,2,4-triazole compound
SI1555267T1 (sl) 2,3-DIHIDRO-6-NITROIMIDAZO(2,1-b)OKSAZOLI
PL377187A1 (pl) Związki ze skondensowanym pierścieniem 1,3-dihydroimidazolowym
GB0229015D0 (en) New Compound
MXPA03009558A (es) Compuestos novedosos.
GB0208279D0 (en) Novel compounds
GB0119467D0 (en) Novel compound
GB0217431D0 (en) Novel compounds
GB0205256D0 (en) Novel compounds
GB0211019D0 (en) Novel compounds
GB0221828D0 (en) Novel compound
GB0221829D0 (en) Novel compound
PL397821A1 (pl) Związek1-acetylo-6-fluoro-2-indolinon
GB0218147D0 (en) Novel compounds
GB0204241D0 (en) Compound
GB0224830D0 (en) Compound
GB0213027D0 (en) Compound
GB0207637D0 (en) Novel compound
GB0207450D0 (en) Novel compounds
SI1497256T1 (sl) Substituirane 1,5-diaminopentan-3-olne spojine
GB0207432D0 (en) Novel compounds
GB0207439D0 (en) Novel compounds
ZA200407363B (en) Novel compounds.
GB0223287D0 (en) Novel compound